These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
205 related items for PubMed ID: 18571421
1. Studies toward the discovery of the next generation of antidepressants. Part 6: Dual 5-HT1A receptor and serotonin transporter affinity within a class of arylpiperazinyl-cyclohexyl indole derivatives. Zhou D, Zhou P, Evrard DA, Meagher K, Webb M, Harrison BL, Huryn DM, Golembieski J, Hornby GA, Schechter LE, Smith DL, Andree TH, Mewshaw RE. Bioorg Med Chem; 2008 Jul 15; 16(14):6707-23. PubMed ID: 18571421 [Abstract] [Full Text] [Related]
2. Studies toward the discovery of the next generation of antidepressants. 3. Dual 5-HT1A and serotonin transporter affinity within a class of N-aryloxyethylindolylalkylamines. Mewshaw RE, Zhou D, Zhou P, Shi X, Hornby G, Spangler T, Scerni R, Smith D, Schechter LE, Andree TH. J Med Chem; 2004 Jul 15; 47(15):3823-42. PubMed ID: 15239661 [Abstract] [Full Text] [Related]
4. Design and synthesis of long-chain arylpiperazines with mixed affinity for serotonin transporter (SERT) and 5-HT(1A) receptor. Perrone R, Berardi F, Colabufo NA, Lacivita E, Larizza C, Leopoldo M, Tortorella V. J Pharm Pharmacol; 2005 Oct 15; 57(10):1319-27. PubMed ID: 16259761 [Abstract] [Full Text] [Related]
5. Synthesis, docking and pharmacological evaluation of novel homo- and hetero-bis 3-piperazinylpropylindole derivatives at SERT and 5-HT1A receptor. Pessoa-Mahana H, González-Lira C, Fierro A, Zapata-Torres G, Pessoa-Mahana CD, Ortiz-Severin J, Iturriaga-Vásquez P, Reyes-Parada M, Silva-Matus P, Saitz-Barría C, Araya-Maturana R. Bioorg Med Chem; 2013 Dec 15; 21(24):7604-11. PubMed ID: 24262884 [Abstract] [Full Text] [Related]
8. Indolebutylamines as selective 5-HT(1A) agonists. Heinrich T, Böttcher H, Bartoszyk GD, Greiner HE, Seyfried CA, Van Amsterdam C. J Med Chem; 2004 Sep 09; 47(19):4677-83. PubMed ID: 15341483 [Abstract] [Full Text] [Related]
9. Synthesis and SAR of highly potent dual 5-HT1A and 5-HT1B antagonists as potential antidepressant drugs. Kling A, Lange UE, Mack H, Bakker MH, Drescher KU, Hornberger W, Hutchins CW, Möller A, Müller R, Schmidt M, Unger L, Wicke K, Schellhaas K, Steiner G. Bioorg Med Chem Lett; 2005 Dec 15; 15(24):5567-73. PubMed ID: 16219465 [Abstract] [Full Text] [Related]
10. Novel benzofuran derivatives with dual 5-HT1A receptor and serotonin transporter affinity. Venkatesan AM, Dos Santos O, Ellingboe J, Evrard DA, Harrison BL, Smith DL, Scerni R, Hornby GA, Schechter LE, Andree TH. Bioorg Med Chem Lett; 2010 Feb 01; 20(3):824-7. PubMed ID: 20064720 [Abstract] [Full Text] [Related]
13. Synthesis, anticonvulsant activity and 5-HT1A, 5-HT2A receptor affinity of new N-[(4-arylpiperazin-1-yl)-alkyl] derivatives of 2-azaspiro[4.4]nonane and [4.5]decane-1,3-dione. Obniska J, Kołaczkowski M, Bojarski AJ, Duszyńska B. Eur J Med Chem; 2006 Jul 01; 41(7):874-81. PubMed ID: 16600439 [Abstract] [Full Text] [Related]
20. Benzimidazole derivatives. Part 5: design and synthesis of new benzimidazole-arylpiperazine derivatives acting as mixed 5-HT1A/5-HT3 ligands. López-Rodríguez ML, Benhamú B, Morcillo MJ, Tejada I, Avila D, Marco I, Schiapparelli L, Frechilla D, Del Río J. Bioorg Med Chem; 2004 Oct 01; 12(19):5181-91. PubMed ID: 15351401 [Abstract] [Full Text] [Related] Page: [Next] [New Search]